Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol. 2016;22(4):458-465. Published online 2016 Dec 25 DOI: https://doi.org/10.3350/cmh.2016.0054
|
Citations to this article as recorded by
5-FU promotes HBV replication through oxidative stress-induced autophagy dysfunction
Jing Yang, Luyan Zheng, Zhenggang Yang, Zhiqiang Wei, Jiajia Shao, Yina Zhang, Jiping Yao, Minwei Li, Xueyu Wang, Min Zheng
Free Radical Biology and Medicine.2024; 213: 233. CrossRef Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors
Jiaming Shen, Xia Wang, Guangde Yang, Li Li, Juanjuan Fu, Wei Xu, Qingqiao Zhang, Xiucheng Pan
Journal of Hepatocellular Carcinoma.2024; Volume 11: 207. CrossRef Sorafenib plus transcatheter arterial chemoembolization with or without camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma
Bo Sun, Lei Chen, Yu Lei, Lijie Zhang, Tao Sun, Yiming Liu, Chuansheng Zheng
British Journal of Radiology.2024; 97(1159): 1320. CrossRef TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Haohao Lu, Chuansheng Zheng, Bin Xiong, Xiangwen Xia
BMC Cancer.2023;[Epub] CrossRef S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, Claus Niederau, Frank Tacke, Thomas Berg, Dieter Glebe, Wolfgang Jilg, Heiner Wedemeyer, Stefan Wirth, Christoph Höner zu Siederdissen, Petra Lynen-Jansen, Pia van Leeuwen, Jörg Petersen
Zeitschrift für Gastroenterologie.2021; 59(07): 691. CrossRef Association of Prophylactic Anti–Hepatitis B Virus Therapy With Improved Long-term Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Therapy
Jeong Won Jang, Sun Hong Yoo, Hee Chul Nam, Bo Hyun Jang, Pil Soo Sung, Sung, Won Lee, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Seung Kew Yoon, Jong Young Choi
Clinical Infectious Diseases.2020; 71(3): 546. CrossRef Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review
Mohamed A Abd El Aziz, Rodolfo Sacco, Antonio Facciorusso
Antiviral Chemistry and Chemotherapy.2020; 28: 204020662092133. CrossRef Efficacy of microwave ablation and entecavir as a combination treatment for primary liver cancer and their effects on hepatitis B virus and liver function
Hong Xu, Qiang Zhang, Yu-Lin Tan, Yang Zhang, Jian-Zhu Wei, Ling-Ling Wang, Bo Xie
All Life.2020; 13(1): 524. CrossRef Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis
Su-Su Zhang, Jin-Xia Liu, Jing Zhu, Ming-Bing Xiao, Cui-Hua Lu, Run-Zhou Ni, Li-Shuai Qu
Japanese Journal of Clinical Oncology.2019; 49(7): 646. CrossRef Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
Baek Gyu Jun, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Seong Hee Kang, Moon Young Kim, Soon Koo Baik, Minjong Lee, Tae-Suk Kim, Dae Hee Choi, Sang-Hyeon Choi, Ki Tae Suk, Dong Joon Kim, Ga
PLOS ONE.2018; 13(7): e0201316. CrossRef
|